Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study.

Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study.

Item
http://www.wikidata.org/entity/Q37051820
Bone and TNF in rheumatoid arthritis: clinical implicationsEffects of anti-tumor necrosis factor α agents on boneNovel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of AssaysBiologic therapies and bone loss in rheumatoid arthritis.Glucocorticoids: bad or safe for the bones?Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseasesBone effects of biologic drugs in rheumatoid arthritis.Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral densityOsteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease.Osteoporosis and osteoarthritis, rheumatoid arthritis and spondylarthropathies.Management of osteoporosis in rheumatoid arthritis patients.Opioid Use and Risk of Nonvertebral Fractures in Adults With Rheumatoid Arthritis: A Nested Case-Control Study Using Administrative Databases.Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture.Rates of non-vertebral osteoporotic fractures in rheumatoid arthritis and postfracture osteoporosis care in a period of evolving clinical practice guidelines.Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over.Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.RANKL: A therapeutic target for bone destruction in rheumatoid arthritis.
P2860

Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study.

Item
http://www.wikidata.org/entity/Q37051820
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of disease-modifying a ...... population-based cohort study.
@en
Effects of disease-modifying a ...... population-based cohort study.
@nl
type
label
Effects of disease-modifying a ...... population-based cohort study.
@en
Effects of disease-modifying a ...... population-based cohort study.
@nl
prefLabel
Effects of disease-modifying a ...... population-based cohort study.
@en
Effects of disease-modifying a ...... population-based cohort study.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Effects of disease-modifying a ...... population-based cohort study
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932